Browsing by Author "Martínez-Ciarpaglini, Carolina"

Sort by: Order: Results:

  • Targeted immunotherapy against distinct cancer-associated fibroblasts overcomes treatment resistance in refractory HER2+ breast tumors
    Rivas, Elisa; Linares Aceituno, Jenniffer Lissethe; Zwick, Melissa; Gómez-Llonín, Andrea; Guiu, Marc; Labernadie, Anna; Badia-Ramentol, Jordi; Lladó, Anna; Bardia, Lídia; Pérez-Núñez, Iván; Martínez-Ciarpaglini, Carolina; Tarazona, Noelia; Sallent-Aragay, Anna; Garrido, Marta; Celià-Terrassa, Toni; Burgués, Octavio; Gomis, Roger R.; Albanell Mestres, Joan; Calon, Alexandre (Nature Research, 2022)
    About 50% of human epidermal growth factor receptor 2 (HER2)+ breast cancer patients do not benefit from HER2-targeted therapy and almost 20% of them relapse after treatment. Here, we conduct a detailed analysis of two ...
  • The prognostic potential of CDX2 in colorectal cancer: Harmonizing biology and clinical practice
    Badia-Ramentol, Jordi; Gimeno-Valiente, Francisco; Duréndez, Elena; Martínez-Ciarpaglini, Carolina; Linares Aceituno, Jenniffer Lissethe; Iglesias Coma, Mar; Cervantes, Andrés; Calon, Alexandre; Tarazona, Noelia (Elsevier, 2023)
    Adjuvant chemotherapy following surgical intervention remains the primary treatment option for patients with localized colorectal cancer (CRC). However, a significant proportion of patients will have an unfavorable outcome ...

Search DSpace

Browse

My Account

In collaboration with Compliant to Partaking